MoneyWorks4Me

Hind Bio Science - Quaterly Results

01 Feb 2026 Evaluate
The revenue for the December 2025 quarter is pegged at Rs. 3.82 millions against Rs. 0.00 millions recorded during the year-ago period.The Total Profit for the quarter ended December 2025 of Rs. 0.81 millions grew from Rs.-0.41 millions Operating profit Margin for the quarter ended December 2025 improved to 0.94% as compared to -0.41% of corresponding quarter ended December 2024


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202512 202412 % Var 202512 202412 % Var 202503 202403 % Var
Sales 3.82 0.00 0.00 7.04 8.22 -14.36 8.13 10.39 -21.75
Other Income 0.18 0.00 0.00 0.40 0.28 42.86 0.00 0.14 0.00
PBIDT 0.94 -0.41 -329.27 0.53 1.22 -56.56 0.99 0.63 57.14
Interest 0.01 0.00 0.00 0.02 0.00 0.00 0.01 0.04 -75.00
PBDT 0.93 -0.41 -326.83 0.51 1.22 -58.20 0.98 0.59 66.10
Depreciation 0.12 0.00 0.00 0.16 0.00 0.00 0.00 0.07 -100.00
PBT 0.81 -0.41 -297.56 0.35 1.22 -71.31 0.98 0.52 88.46
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 -0.04 -25.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.03 -0.04 -25.00
PAT 0.81 -0.41 -297.56 0.35 1.22 -71.31 1.01 0.56 80.36
Equity 20.50 20.50 0.00 20.50 20.50 0.00 20.50 20.50 0.00
PBIDTM(%) 24.61 0.00 0.00 7.53 14.84 -49.28 12.18 6.06 100.83
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..